![]() | Up a level |
Kudo, Masatoshi, Ueshima, Kazuomi, Ikeda, Masafumi, Torimura, Takuji, Tanabe, Nobukazu, Aikata, Hiroshi, Izumi, Namiki, Yamasaki, Takahiro, Nojiri, Shunsuke, Hino, Keisuke et al (show 17 more authors)
(2022)
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarteria Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma.
LIVER CANCER, 11 (4).
pp. 354-367.
Kudo, Masatoshi ORCID: 0000-0002-4102-3474, Finn, Richard S
ORCID: 0000-0003-2494-2126, Qin, Shukui, Han, Kwang-Hyub, Ikeda, Kenji, Cheng, Ann-Lii
ORCID: 0000-0002-9152-6512, Vogel, Arndt
ORCID: 0000-0003-0560-5538, Tovoli, Francesco
ORCID: 0000-0002-8350-1155, Ueshima, Kazuomi
ORCID: 0000-0002-7577-5789, Aikata, Hiroshi
ORCID: 0000-0002-3409-2156 et al (show 10 more authors)
(2023)
Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study.
Journal of hepatology, 78 (1).
pp. 133-141.
Kudo, Masatoshi, Ueshima, Kazuomi, Ikeda, Masafumi, Torimura, Takuji, Tanabe, Nobukazu, Aikata, Hiroshi, Izumi, Namiki, Yamasaki, Takahiro, Nojiri, Shunsuke, Hino, Keisuke et al (show 18 more authors)
(2020)
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.
Gut, 69 (8).
pp. 1492-1501.
Kudo, Masatoshi, Ueshima, Kazuomi, Yokosuka, Osamu, Ogasawara, Sadahisa, Obi, Shuntaro, Izumi, Namiki, Aikata, Hiroshi, Nagano, Hiroaki, Hatano, Etsuro, Sasaki, Yutaka et al (show 13 more authors)
(2018)
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.
LANCET GASTROENTEROLOGY & HEPATOLOGY, 3 (6).
pp. 424-432.